Live Breaking News & Updates on Alnylam Pharmaceuticals Stock Performance

Stay updated with breaking news from Alnylam pharmaceuticals stock performance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Receives Average Recommendation of "Moderate Buy" from Analysts

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the seventeen brokerages that are currently covering the stock, MarketBeat.com reports. Seven investment analysts have rated the stock with a hold rating and ten have issued a buy rating on the company. The average 1-year price target among […] ....

Institutional Investors Weigh In On Alnylam Pharmaceuticals , Jpmorgan Chase Co , Alnylam Pharmaceuticals , Royal Bank , Altitude Crest Partners Inc , Alnylam Pharmaceuticals Stock Performance , Alnylam Pharmaceuticals Inc , Wolfe Research , News Ratings For Alnylam Pharmaceuticals Daily , Allspring Global Investments Holdings , Analyst Recommendations For Alnylam Pharmaceuticals , Investment Management , Quent Capital , Get Free Report , Global Investments Holdings , Crest Partners , Get Free , Alnylam Pharmaceuticals Daily ,

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Shares Purchased by Vanguard Personalized Indexing Management LLC

Vanguard Personalized Indexing Management LLC raised its stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 11.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,390 shares of the biopharmaceutical company’s stock after acquiring an additional 655 shares during […] ....

United States , News Ratings For Alnylam Pharmaceuticals Daily , Wolfe Research , Alnylam Pharmaceuticals , Alnylam Pharmaceuticals Stock Performance , Alnylam Pharmaceuticals Inc , Quarter For Alnylam Pharmaceuticals , Panagora Asset Management Inc , Commonwealth Equity Services , Asset Management Inc , Cantor Fitzgerald , Raymond James Associates , Goldman Sachs Group , Exchange Commission , Vanguard Personalized Indexing Management , Free Report , Personalized Indexing Management , Equity Services , Management Inc , Asset Management , Teacher Retirement System , Retirement System , Get Free Report , Visit Holdingschannel , Alnylam Pharmaceuticals Daily , Nasdaq Alny ,

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Shares Acquired by E Fund Management Co. Ltd.

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Shares Acquired by E Fund Management Co. Ltd.
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Zurcher Kantonalbank Zurich Cantonalbank , Raymond James Associates , Quarter For Alnylam Pharmaceuticals , Goldman Sachs Group , News Ratings For Alnylam Pharmaceuticals Daily , Fund Management Co , Exchange Commission , E Fund Management Co , Mirae Asset Global Investments Co , Commonwealth Equity Services , Needham Company , Royal Bank , Alnylam Pharmaceuticals Inc , Investors Pty Ltd , Alnylam Pharmaceuticals Stock Performance , Alnylam Pharmaceuticals , Free Report , Fund Management , Equity Services , Kantonalbank Zurich Cantonalbank , Pty Ltd , Mirae Asset Global Investments , Asset Global Investments , Get Free Report , Alnylam Pharmaceuticals Daily ,

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Receives $215.88 Consensus PT from Brokerages

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has been assigned an average rating of “Moderate Buy” from the seventeen ratings firms that are currently covering the stock, Marketbeat reports. Seven investment analysts have rated the stock with a hold recommendation and ten have assigned a buy recommendation to the company. The average 1 year […] ....

Morgan Stanley , Alnylam Pharmaceuticals Stock Performance , Institutional Trading Of Alnylam Pharmaceuticals , Investment Management , Wolfe Research , Alnylam Pharmaceuticals , Quent Capital , Analyst Recommendations For Alnylam Pharmaceuticals , Alnylam Pharmaceuticals Inc , Allspring Global Investments Holdings , News Ratings For Alnylam Pharmaceuticals Daily , Wells Fargo Company , Cantor Fitzgerald , Get Free Report , Global Investments Holdings , Get Free , Alnylam Pharmaceuticals Daily , Nasdaq Alny ,

Alnylam Pharmaceuticals' (ALNY) "Buy" Rating Reaffirmed at Chardan Capital

Alnylam Pharmaceuticals' (ALNY) "Buy" Rating Reaffirmed at Chardan Capital
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

William Blair , Alnylam Pharmaceuticals , Alnylam Pharmaceuticals Inc , Ep Wealth Advisors , Royal Bank , Oppenheimer Co , Harbor Capital Advisors Inc , Alnylam Pharmaceuticals Company Profile , Analyst Recommendations For Alnylam Pharmaceuticals , Institutional Investors Weigh In On Alnylam Pharmaceuticals , Wells Fargo Company , Alnylam Pharmaceuticals Stock Performance , Envestnet Portfolio Solutions Inc , Jpmorgan Chase Co , News Ratings For Alnylam Pharmaceuticals Daily , Commerce Bank , Chardan Capital , Free Report , Wells Fargo , Moderate Buy , Get Free Report , Capital Advisors , Portfolio Solutions , Alnylam Pharmaceuticals Daily ,